JP2022548472A5 - - Google Patents
Info
- Publication number
- JP2022548472A5 JP2022548472A5 JP2022506595A JP2022506595A JP2022548472A5 JP 2022548472 A5 JP2022548472 A5 JP 2022548472A5 JP 2022506595 A JP2022506595 A JP 2022506595A JP 2022506595 A JP2022506595 A JP 2022506595A JP 2022548472 A5 JP2022548472 A5 JP 2022548472A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- polypeptide
- amino acid
- amino acids
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962903441P | 2019-09-20 | 2019-09-20 | |
| US62/903,441 | 2019-09-20 | ||
| US202062990693P | 2020-03-17 | 2020-03-17 | |
| US62/990,693 | 2020-03-17 | ||
| US202063048561P | 2020-07-06 | 2020-07-06 | |
| US63/048,561 | 2020-07-06 | ||
| PCT/US2020/051255 WO2021055594A1 (en) | 2019-09-20 | 2020-09-17 | T-cell modulatory polypeptides and methods of use thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022548472A JP2022548472A (ja) | 2022-11-21 |
| JP2022548472A5 true JP2022548472A5 (enExample) | 2023-09-25 |
| JP7756072B2 JP7756072B2 (ja) | 2025-10-17 |
Family
ID=74884186
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022506595A Active JP7756072B2 (ja) | 2019-09-20 | 2020-09-17 | Ｔ細胞調節ポリペプチド及びその使用方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20220143063A1 (enExample) |
| EP (1) | EP4030897A4 (enExample) |
| JP (1) | JP7756072B2 (enExample) |
| KR (1) | KR20220066075A (enExample) |
| CN (1) | CN114423284A (enExample) |
| AU (1) | AU2020348373A1 (enExample) |
| CA (1) | CA3146591A1 (enExample) |
| IL (1) | IL290635A (enExample) |
| MX (1) | MX2022003367A (enExample) |
| TW (1) | TW202126683A (enExample) |
| WO (1) | WO2021055594A1 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110325205B (zh) | 2016-12-22 | 2023-08-15 | 库尔生物制药有限公司 | T细胞调节性多聚体多肽及其使用方法 |
| KR20240005989A (ko) | 2017-03-15 | 2024-01-12 | 큐 바이오파마, 인크. | 면역 반응을 조절하는 방법 |
| WO2019051127A1 (en) | 2017-09-07 | 2019-03-14 | Cue Biopharma, Inc. | MULTIMER MODULATOR POLYPEPTIDE OF LYMPHOCYTE T HAVING CONJUGATION SITES AND METHODS OF USE THEREOF |
| TWI856047B (zh) * | 2018-12-19 | 2024-09-21 | 美商信號生物製藥公司 | 多聚體ｔ細胞調節多肽及其使用方法 |
| WO2021087840A1 (zh) * | 2019-11-07 | 2021-05-14 | 武汉华大吉诺因生物科技有限公司 | 肿瘤免疫治疗多肽及其应用 |
| IL296209A (en) | 2020-05-12 | 2022-11-01 | Cue Biopharma Inc | Multimeric t-cell modulatory polypeptides and methods of using them |
| JP2023541366A (ja) | 2020-09-09 | 2023-10-02 | キュー バイオファーマ， インコーポレイテッド | １型真性糖尿病（ｔ１ｄ）を治療するためのｍｈｃクラスｉｉ ｔ細胞調節多量体ポリペプチド及びその使用方法 |
| US11058751B1 (en) * | 2020-11-20 | 2021-07-13 | Think Therapeutics, Inc. | Compositions for optimized RAS peptide vaccines |
| CN116710115A (zh) | 2020-11-20 | 2023-09-05 | 思维疗法股份有限公司 | 用于优化的肽疫苗的组合物和方法 |
| US11421015B2 (en) | 2020-12-07 | 2022-08-23 | Think Therapeutics, Inc. | Method of compact peptide vaccines using residue optimization |
| WO2022140759A2 (en) * | 2020-12-23 | 2022-06-30 | Janssen Biotech, Inc. | Neoantigen peptide mimics |
| EP4308143A4 (en) * | 2021-03-19 | 2025-06-04 | Cue Biopharma, Inc. | T-cell modulatory polypeptides and methods of use thereof |
| US11464842B1 (en) | 2021-04-28 | 2022-10-11 | Think Therapeutics, Inc. | Compositions and method for optimized peptide vaccines using residue optimization |
| EP4504802A4 (en) * | 2022-04-07 | 2026-03-25 | Cue Biopharma Inc | IMMUNE CELL BINDING POLYPEPTIDES |
| CN115820736B (zh) * | 2022-12-08 | 2024-05-10 | 西南大学 | 家蚕丝胶蛋白Ser4在提高蚕丝性能中的应用及其方法 |
| WO2024264007A2 (en) * | 2023-06-23 | 2024-12-26 | Cue Biopharma, Inc. | T-cell modulatory polypeptides and methods of use thereof |
| WO2024264004A2 (en) * | 2023-06-23 | 2024-12-26 | Cue Biopharma, Inc. | T-cell modulatory polypeptides and methods of use thereof |
| WO2026125765A1 (en) | 2024-12-13 | 2026-06-18 | Immunoscape Pte. Ltd. | Combination therapy |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6652932B2 (ja) * | 2014-06-18 | 2020-02-26 | アルバート アインシュタイン カレッジ オブ メディシン | ｓｙｎＴａｃポリペプチド及びその使用 |
| EP3286222A4 (en) | 2015-03-23 | 2018-08-08 | The Johns Hopkins University | Hla-restricted epitopes encoded by somatically mutated genes |
| RU2018130525A (ru) * | 2016-01-27 | 2020-02-27 | Цсл Беринг Ленгнау Аг | РЕКОМБИНАНТНЫЕ Fc-МУЛЬТИМЕРЫ IgG |
| CA3014458A1 (en) * | 2016-03-02 | 2017-09-08 | Cue Biopharma, Inc. | T-cell modulatory multimeric polypeptides and methods of use thereof |
| WO2017151940A2 (en) * | 2016-03-03 | 2017-09-08 | Cue Biopharma, Inc. | T-cell modulatory multimeric polypeptides and methods of use thereof |
| SG11201808552XA (en) * | 2016-05-18 | 2018-10-30 | Cue Biopharma Inc | T-cell modulatory multimeric polypeptides and methods of use thereof |
| CN110325205B (zh) * | 2016-12-22 | 2023-08-15 | 库尔生物制药有限公司 | T细胞调节性多聚体多肽及其使用方法 |
| US11851471B2 (en) * | 2017-01-09 | 2023-12-26 | Cue Biopharma, Inc. | T-cell modulatory multimeric polypeptides and methods of use thereof |
| KR20240005989A (ko) * | 2017-03-15 | 2024-01-12 | 큐 바이오파마, 인크. | 면역 반응을 조절하는 방법 |
| WO2019051127A1 (en) * | 2017-09-07 | 2019-03-14 | Cue Biopharma, Inc. | MULTIMER MODULATOR POLYPEPTIDE OF LYMPHOCYTE T HAVING CONJUGATION SITES AND METHODS OF USE THEREOF |
| WO2019139896A1 (en) * | 2018-01-09 | 2019-07-18 | Cue Biopharma, Inc. | Multimeric t-cell modulatory polypeptides and methods of use thereof |
| KR20230009426A (ko) | 2020-05-12 | 2023-01-17 | 스미토모 파마 가부시키가이샤 | 암을 처치하기 위한 의약 조성물 |
-
2020
- 2020-09-17 EP EP20865317.0A patent/EP4030897A4/en active Pending
- 2020-09-17 MX MX2022003367A patent/MX2022003367A/es unknown
- 2020-09-17 CN CN202080065140.0A patent/CN114423284A/zh active Pending
- 2020-09-17 WO PCT/US2020/051255 patent/WO2021055594A1/en not_active Ceased
- 2020-09-17 KR KR1020227009918A patent/KR20220066075A/ko not_active Withdrawn
- 2020-09-17 JP JP2022506595A patent/JP7756072B2/ja active Active
- 2020-09-17 AU AU2020348373A patent/AU2020348373A1/en not_active Abandoned
- 2020-09-17 CA CA3146591A patent/CA3146591A1/en active Pending
- 2020-09-18 TW TW109132369A patent/TW202126683A/zh unknown
-
2022
- 2022-01-25 US US17/584,133 patent/US20220143063A1/en not_active Abandoned
- 2022-02-15 IL IL290635A patent/IL290635A/en unknown
-
2024
- 2024-10-01 US US18/903,947 patent/US20250120996A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022534846A5 (enExample) | ||
| JP2020514375A5 (enExample) | ||
| CA3089333C (en) | Anti-pdl1, il-15 and tgf-beta receptor combination molecules | |
| JP2024512470A5 (enExample) | ||
| JP2018525006A5 (enExample) | ||
| JP2020511949A5 (enExample) | ||
| JP2021500855A5 (enExample) | ||
| JP7783164B2 (ja) | 改変インターロイキン２受容体ベータアゴニスト | |
| CN114728040A (zh) | 新型白介素-2变体及其双功能融合分子 | |
| JP2023526723A5 (enExample) | ||
| KR20220148304A (ko) | 병용 약학 조성물 | |
| IL308851B1 (en) | T cell modulatory multimeric polypeptides and methods of using them | |
| CN117986384A (zh) | 与il-12和il-18的基于il-15的融合物 | |
| JP2017519491A5 (enExample) | ||
| JP2021522835A (ja) | 二機能性結合ポリペプチド | |
| US20230414777A1 (en) | Antigen Presenting Polypeptide Complexes and Methods of Use Thereof | |
| CN116981470A (zh) | T细胞调节多肽和其使用方法 | |
| JP2022515331A5 (enExample) | ||
| BR112021011838A2 (pt) | Peptídeos multiméricos moduladores de células t e métodos de uso destes | |
| US11484572B2 (en) | Use of HLA-B27 homodimers for cancer treatment | |
| JP2024541334A5 (enExample) | ||
| JP2024518680A5 (enExample) | ||
| US20200399344A1 (en) | Nk cell-directed chimeric proteins | |
| JP2024537096A (ja) | がんの治療のための代替的なＰＤ１－ＩＬ７ｖイムノコンジュゲート | |
| CA3216278A1 (en) | Antigen presenting polypeptide complexes bearing tgf-beta and methods of use thereof |